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in white-beaked dolphins. We do not 
know how the dolphin contracted the 
infection and whether this remains an 
isolated case or the beginning of a new 
zoonosis.
White-beaked dolphins are found 
in moderate and subarctic waters of 
the Atlantic Ocean between the eastern 
coast of North America and northern 
Europe. They may migrate hundreds 
of kilometers within days. Therefore, 
these dolphins may play a role as a 
reservoir and vector for this morbil-
livirus, which is infectious for harbor 
porpoises, bottlenose dolphins, and 
other cetacean species (10). The reap-
pearance of a morbillivirus represents 
a serious threat to susceptible marine 
mammals in northern European and 
American waters, with potentially 
devastating consequences and possi-
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Bartonella australis 
sp. nov. from 
Kangaroos, 
Australia
To the Editor: During April–May 
1999, 3 Bartonella isolates (AUST/
NH1, AUST/NH2, AUST/NH3) 
were cultivated and established from 
the blood of 5 Macropus giganteus 
gray kangaroos from central coastal 
Queensland, Australia. We used mul-
tigene sequencing to evaluate whether 
these  Bartonella isolates fulﬁ  ll  the 
minimum requirements for classiﬁ  ca-
tion as a new species.
DNA from each Bartonella isolate 
was extracted by using the QIAamp 
tissue kit (QIAGEN, Hilden, Germa-
ny) according to the manufacturer’s 
instructions. Partial PCR ampliﬁ  ca-
tion and sequencing of the genes en-
coding the 16S rDNA (rrs), citrate 
synthase (gltA), β-subunit of the RNA 
polymerase (rpoB), and cell division 
protein (ftsZ), as well as for the 16S–
23S rDNA intergenic spacer (ITS) 
were attempted by using previously 
described primers and conditions (1). 
Bartonella sp. isolates AUST/NH1 
to AUST/NH3 exhibited identical se-
quences for all 4 genes and the spacer 
studied, and isolate AUST/NH1 was 
selected as type strain among kanga-
roo isolates. Similarity rates between 
strain Aust/NH1 and validated Barton-
ella species (online Appendix Table, 
available from www.cdc.gov/EID/
content/13/12/1961-appT.htm) ranged 
from 84.7% to 91.6%, from 97.5% to 
98.5%, from 79.6% to 87.2%, from 
85.4% to 95.0%, and from 83.5% to 
87.1% for the ITS and rrs, gltA, rpoB, 
and  ftsZ genes, respectively. There-
fore, for each of these 4 genes or the 
spacer,  strain AUST/NH1 exhibited 
similarity rates with all other species 
lower than the cutoffs published to 
classify  Bartonella isolates within a 
validated species (1). It may thus be 
regarded as a new species.
To estimate the genomic G+C 
content of strain AUST/NH1, we am-
pliﬁ   ed and sequenced its ftsY gene 
as described (2) by using the Bartft-
syF (5′-ATGACAAAAYCYTTTAT-
MAA-3′) and BartftsyR (5′-TCAT-
GAGTGTCTTCCTGC-3′) primers. 
The ftsY G+C content was 37.7%; the 
calculated genomic G+C content was 
39.51%. The ftsY sequence was depos-
ited in GenBank under accession no. 
DQ538398.
The phylogenetic relationships 
among the studied bartonellae were 
inferred from sequence alignments of 
each gene and from concatenated gene 
sequences by using the maximum par-
simony and neighbor-joining methods 
within the MEGA version 2.1 soft-
ware package (3) and the maximum-
likelihood method within the PHYLIP 
software package (4). Using rrs, gltA, 
and rpoB sequences, the phylogenetic 
position of strain AUST/NH1 was 
supported by bootstrap values <70%. 
In contrast, by using the ITS, ftsZ, 
and concatenated sequences, strain 
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AUST/NH1 clustered with a group 
of B. tribocorum, B. grahamii, and B. 
elizabethae, with elevated bootstrap 
values according to the 3 analysis 
methods (Figure).
The  Bartonella strains we de-
scribe are the ﬁ  rst, to our knowledge, 
obtained from kangaroos and, more 
generally, from marsupials. Before 
this study, the only 2 Bartonella spe-
cies found in Australia were B. hense-
lae (5) and B. quintana (6). We dem-
onstrated that strain AUST/NH1 was 
reliably associated with a well-estab-
lished cluster, including the rodent-as-
sociated B. elizabethae, B. grahamii, 
and B. tribocorum (7). Therefore, we 
are conﬁ  dent that the phylogenic po-
sition of the new Bartonella,  which 
was similar  according to 3 analysis 
methods and supported by high boot-
strap values, is reliable. Although B. 
grahamii (8) and B. elizabethae (9), 
members of the same phylogenetic 
cluster as strain AUST/NH1, cause 
human infections, the pathogenicity of 
B. tribocorum is as yet unknown. Its 
pathogenicity should therefore be in-
vestigated, especially for persons who 
come in contact with kangaroos. 
B. australis is a facultative in-
tracellular gram-negative bacterium. 
It grows on Columbia agar with 5% 
sheep blood at 32°C to 37°C in a 
moist atmosphere containing 5% CO2. 
A primary culture was obtained after 7 
days, and subculture was obtained af-
ter 4 days under the same conditions. 
Colonies are homogeneous, smooth, 
round, and gray-white. The 3 strains 
tested were oxidase negative, catalase 
negative, and nonmotile. Pathogenic-
ity for humans is, as yet, unknown.
The type strain is strain AUST/
NH1. The new species is distinguished 
from other Bartonella species by its 
16S rRNA, gltA, rpoB, ftsZ gene se-
quences, as well as its 16S–23S rRNA 
ITS sequence. The estimated G+C con-
tent is 38%. The type strain exhibits a 
speciﬁ  c serotype (10) and was suscep-
tible to amoxicillin, ceftriaxone, imi-
penem, erythromycin, clarithromycin, 
oﬂ  oxacin, ciproﬂ  oxacin, rifampin, and 
tetracycline (unpub. data). The type 
strain AUST/NH1 has been deposited 
in the Collection of the World Health 
Organization Collaborative Center for 
Rickettsioses, Borrelioses and Tick-
borne Infections  (CSUR), Marseille, 
France, under reference CSUR B1; 
in the Collection de l’Institut Pasteur 
(CIP) under reference CIP 108978T; 
and in the Culture Collection of the 
University of Göteborg (CCUG), 
Sweden, under reference CCUG 
51999. The strains AUST/NH2 and 
AUST/NH3 have been deposited in 
CSUR under references CSUR B2 and 
CSUR B3, in the CIP under references 
CIP 108980 and CIP 108979, and in 
CCUG under references CCUG 52000 
and CCUG 52001, respectively.
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Q Fever in Migrant 
Workers, Scotland 
To the Editor: Q fever is a zoo-
nosis caused by infection with Coxi-
ella burnetii and is most commonly 
associated with occupational expo-
sure to animal-slaughtering facilities. 
C. burnetii is an obligate intracellular 
bacterium and causes highly variable 
disease, ranging from asymptomatic 
infection to fatal chronic infective en-
docarditis. In June 2006, the United 
Kingdom experienced its largest out-
break of Q fever with 138 cases asso-
ciated with a slaughterhouse near Stir-
ling in Scotland. The slaughterhouse 
had been processing post-parturition 
ewes in the lairage (place for keep-
ing livestock temporarily) at the end 
of May. These animals were thought 
to be among the most likely to shed 
the organism (1). Further investiga-
tion showed that a ewe had aborted in 
the lairage toward the end of May. Al-
though the sheep lairage was the most 
likely source of the infection, no mi-
crobiologic evidence conﬁ  rmed this, 
as C. burnetii was not isolated from 
environmental samples.
The outbreak was neither remark-
able for its putative mode of transmis-
sion nor for the industry involved, but 
both the number and nationalities of 
migrant workers infected was note-
worthy. Since 2004, 12 member states 
have joined the European Union and 
this has led to an inﬂ  ux of immigrants 
to the United Kingdom. The increase 
in migrant numbers has partly been a 
result of the government’s managed 
migration policy, expanding migration 
to  ﬁ  ll vacancies in skilled and low-
wage occupations. Employers have 
difﬁ  culty recruiting UK workers be-
cause of the jobs’ physical demands, 
long hours that limit social activities, 
and low pay. They therefore recruit in-
ternational workers with a good work 
ethic and reliability; central and East-
ern European workers are compared 
favorably with UK nationals (2). Mi-
grants from Eastern and central Eu-
rope are now more likely to be found 
in low-wage occupations in agricul-
ture, construction, hospitality, and au 
pair employment. Of the 138 cases of 
Q fever, 48 were immigrants from the 
following countries: Slovakia (41), 
Poland (3), Czech Republic (2), and 
Lithuania (2). Unsurprisingly, epide-
miologic case interviews were beset 
with linguistic and logistic problems.
The diagnosis of Q fever relies 
predominantly on its serologic legacy 
since asymptomatic seroconversion 
occurs in up to 60% of patients (3). 
Analysis of our cohort found that non-
UK patients were signiﬁ  cantly  less 
likely than their UK counterparts to 
have symptoms (fever, muscle pain, 
joint pain, headache, and cough) and 
to subsequently have Q fever con-
ﬁ  rmed (Table, p<0.001). Twenty-two 
patients (15 UK, 7 non-UK) did not 
complete epidemiologic question-
naires and were therefore not included 
in this analysis.
Furthermore, analysis of cases 
registered with general practitioners 
(GPs) identiﬁ   ed a signiﬁ  cant  differ-
ence (Table, p<0.001) between UK and 
non-UK patients with the latter group 
less likely to be registered with a GP. 
Although most UK residents were reg-
istered with a general practice, only 11 
of 43 non-UK cases were registered. 
Information on GP registration was 
not known for 17 patients, and these 
were not included in the analysis.
Although the investigating health 
board took stringent steps to ensure 
follow-up of all patients, we believe 
that some asymptomatic non-UK pa-
tients may have permanently returned 
to their native countries with undiag-
nosed illness, and subsequently, cannot 
be traced. This unfortunate scenario 
has potentially catastrophic implica-
tions for these patients because proper 
follow-up clinical management of Q 
fever is necessary to prevent possible 
endocarditis (4), unnecessary surgery, 
and premature death.
Persons with known occupational 
hazards have beneﬁ  ted from an effec-
tive Q fever vaccine; abattoir workers 
and farmers are routinely vaccinated 
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Table. χ
2 analysis of Q fever symptoms and GP registration by nationality* 
No. (%) UK natives 
Characteristic Yes No All
Symptoms 
  No  19 (28.4)  25 (15.6)  44
  Yes  56 (46.6)  16 (25.4)  72
 All  75 41 116
GP registered 
  No  1 (21.3)  32 (11.7)  33
  Yes  77 (56.7)  11 (31.3)  88
 All  78 43 121
*Expected nos. in parentheses. GP, general practitioner; UK, United Kingdom.  